ClinicalTrials.govpublic full text
Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin
locally advanced digestive system neuroendocrine carcinoma, locally advanced pancreatic neuroendocrine carcinoma, metastatic digestive system neuroendocrine carcinoma, metastatic pancreatic neuroendocrine carcinoma, refractory digestive system neuroendocrine carcinoma, refractory pancreatic neuroendocrine carcinoma, unresectable digestive system neuroendocrine carcinoma, unresectable pancreatic neuroendocrine carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 886187
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.